
Clarification11 Nov 2026, 11:12 am
Sun Pharma Advanced Research Confirms Regulatory Compliance
AI Summary
Sun Pharma Advanced Research Company Ltd has responded to a clarification sought by BSE Limited, confirming its compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that all required disclosures have been made to the exchanges and that it is unaware of any undisclosed material information. Sun Pharma Advanced Research reiterated its commitment to timely and adequate disclosures as per applicable regulations.
Key Highlights
- Company confirms compliance with SEBI Listing Regulations.
- All required disclosures have been made to stock exchanges.
- No undisclosed material information is known.
- Commitment to timely and adequate disclosures reaffirmed.
Price Impact
More from SPARC
Promoter Reclassification6h ago
Sun Pharma Advanced Research Co. gets stock exchange nod for promoter reclassification
Corporate Governance2 Nov, 8:24 pm
Sun Pharma Advanced Research: Monitoring Agency Report Q3 2026
Quarterly Result2 Nov, 8:11 pm
Sun Pharma Advanced Research Declares Q2 FY27 Financial Results